Narf Industries seeking ways to finance commercialisation of cybersecurity IP

0

Main Market listed cybersecurity company Narf Industries (LON: NARF) has continued to win contracts with US government organisations, but additional funding is likely to be required to take advantage of the opportunities in a total addressable market that is valued at $7.5bn.

US-focused Narf was founded in 2018 and is involved in vulnerability research, software hardening, which reduces the potential for software to be attacked, security protocol and algorithm design. The core technical staff have a wide knowledge of hacking and cyber security.

There is an important relationship with US government agency DARPA, which pays Narf to carry out research and development on specific topics and areas. Narf does not do any of its own speculative development, but software developed for DARPA can be commercialised via a Software-as-a-Service (SaaS) model.

In the 15 months to March 2024, revenues were $7.6m, which was treble the level for the previous twelve months. The reported loss was $1.44m, although that includes a share-based payment cost of £1.02m. A lower proportion of costs related to subcontractors. There was a cash inflow from operating activities of $173,000.

There was $654,000 of cash in the balance sheet. The chief executive has increased the facility made available to the company from $2m to $2.5m and this lasts until July 2025. At the end of March 2024, there was $1.55m drawn down.

Canaccord Genuity says that there could be a joint venture with a third-party investor that would bring in additional capital. Narf could inject its open source code protection IP into the joint venture, which would seek other commercial partners. Currently revenues come from contracted work.

There would be a reorganisation of activities that could hamper short-term progress. Narf has set a target of $20m of revenues in 2027 and this can still be achievable.

The share price fell 18.2% to 0.9p following the results. This reflects the short-term uncertainty. Narf has strong growth prospects, and it is worth keeping an eye on the company as it sets out its plans to take advantage of the potential cybersecurity market.    

AIM movers: Echo Energy funding Tesoro gold concession and Fadel Partners clients delay decision

1

Echo Energy (LON: ECHO) has raised £418,000 at 0.0025p each. The share price jumped 40.6% to 0.0045p/share. The convertible loan note deed has been terminated. The cash will fund initial production at the Tesoro gold concession and prepare for final investment decision on a tailings deposit project. Peterhouse is appointed as joint broker.  

Unusually high levels of share buying have pushed up the share price of Jaywing (LON: JWNG) by 35.7% to 1.9p. The digital marketing services company changed its management in June and increased its lending facility.

Digital marketing technology company Electric Guitar (LON: ELEG) is launching Marcomms.ai as a joint venture with Cyprus-based Exelia Technologies. The combination will benefit from Electric Guitar subsidiary 3radical’s data with the partner’s software expertise. The share price recovered 29.6% to 0.875p.

The National Institute for Health and Care Excellence has chosen the CYP2C19-ID Genedrive (LON: GDR) test as a preferred platform for point-of-care genotype testing for clopidogrel use after strokes. This medicine is used to reduce the risk of heart disease. The test uses a cheek swab. The share price rose 19.7% to 4.55p.

Oil and gas producer Arrow Exploration (LON: AXL) says that the second horizontal well on the 50%-owned Carrizales Norte field in Colombia is producing ahead of expectations. The two wells are boosting group production. The drilling rig has been moved to drill the third well and there will be another after that. There is cash of $11m and should be at a similar level at the end of 2024 as cash generated from production helps to finance the drilling. Zeus has a total risked NAV estimate of 48.8p/share. The share price is 11.3% higher at 32p.

FALLERS

Shareholders have voted in favour of Destiny Pharma (LON: DEST) leaving AIM. There were 87.8% of the votes in favour. The cancelation will happen on 13 August. The share price slipped a further 23.7% to 2.25p.

Content management platform operator Fadel Partners Inc (LON: FADL) has been held back by delayed conversion rates for new customers who are cautious about investing in new software. Cavendish has reduced its 2024 revenues forecast by 9% to $14.8m, up from $14.5m in 2023. Net cash should be better than previously expected because of a higher working capital inflow taking it to $2m. The share price declined 7% to 126p.

Kodal Minerals (LON: KOD) says there have been delays in the shipping of equipment and materials for the 49%-owned Bougouni lithium project in Mali. Blasting is expected to start in September. First production should be before the end of the year. The share price fell 6.19% to 0.53p.

Bushveld Minerals (LON: BMN) produced 838mt of vanadium, taking first half production to 1,700 tonnes of vanadium, which is slightly lower than the corresponding period last year. Lack of funding held back production. Cash costs rose from $26.60/kg to $27.9/kg. Production guidance for 2024 is 3,800-4,000 tonnes of vanadium, which includes Vanchem. The disposal of Vanchem could achieve regulatory approval in October. The share price is 4.17% lower at 0.575p.

HSBC shares jump after announcing bumper buybacks and better-than-expected profits

HSBC stormed higher on Wednesday after announcing a blowout $4.8bn share buyback programme amid rising profits.

The bank reported a profit before tax of $21.6 billion for the half-year period and Q2 profit before tax of $8.9 billion smashed expectations of $7.8 billion.

HSBC shares were 4.1% higher at the time of writing.

The bank’s revenue saw a modest increase of 1%, rising to $37.3 billion. This growth was partially attributed to gains from strategic transactions, including the disposal of its Canadian banking business, which resulted in a $4.8 billion gain. However, these positive results were somewhat offset by an impairment of $1.2 billion related to the classification of its Argentine business as held for sale.

The bank’s performance was bolstered by increased customer activity in Wealth products within its Wealth and Personal Banking division, as well as in Equities and Securities Financing in Global Banking and Markets.

“HSBC delivers a massive profit beat as Noel Quinn says goodbye. The beat was split evenly across strength in underlying profitability and lower impairments. Borrowers are clinging on, even improving in some places, despite interest rates that many haven’t had to handle for quite some year, or ever in the case of younger borrowers. The outlook on loan losses is decent too, with management signalling the worst of the Chinese commercial real estate drama now in the rear-view mirror,” said Matt Britzman, senior equity analyst, Hargreaves Lansdown.

“A greater focus on Wealth Management is bearing fruit and should allow HSBC to take advantage of the burgeoning middle class in regions like China. There’s also the added bonus of diversification away from interest rates, a key strategic priority over the past few years. With rate cuts expected around the globe, these actions should give Georges Elhedery a strong foundation to work from when he steps up to the CEO seat in September.”

HSBC’s net interest margin (NIM) decreased by 8 basis points to 1.62% compared to the first half of 2023, reflecting the higher cost of interest on liabilities which weren’t covered by interest income. This, however, was much better than analysts thought going into earnings.

HSBC expects banking net interest income to reach around $43 billion in 2024, although this guidance remains dependent on global interest rate trends.

CEO Noel Quinn is to step down but ensured he left with a bang by announcing a $4.8 billion share buyback programme.

“After delivering record profits in 2023, we had another strong profit performance in the first half of 2024, which is further evidence that our strategy is working.” said Noel Quinn Group Chief Executive.

“Our investment in Wealth is delivering higher, more diversified revenue and we continue to grow our core international and scale businesses, all of which helped us to provide $13.7bn of distributions in respect of the first half. We are confident that we have the right strategy and model to grow revenue, even in a lower interest rate environment, and are therefore providing new guidance of a mid-teens return on average tangible equity in 2025.

I have always been immensely proud of the heritage of this bank and the strategic role it plays in the world. My aim when I took this job was to deliver financial performance to match our standing. Working together, I believe we have done that and created a strong platform for growth.”

Vietnam’s Semiconductor Dreams 

Thanks in part to the demand for AI applications, semiconductor chips have become one of the most important tech products globally.  

Nvidia, the cutting-edge chip designer, has seen its market cap explode over the last year and is now one of the world’s most valuable companies. Taiwan Semiconductor Manufacturing Company (TSMC), the leading producer of high-end chips, has become a household name for many. 

Semiconductors are also at the center of the U.S.-China rivalry, with the former introducing ever-stricter export controls to prevent powerful chips from reaching the latter’s weapons systems, smartphones, and other tech.   

The Vietnamese government has correctly identified the semiconductor industry as a key sector for future growth. Vietnam is already a significant hub for chip testing and packaging, with companies such as Intel and Amkor operating large plants in the country. 

Our research shows that in 2021, semiconductors accounted for 19% of Vietnam’s tech exports by value, up from 11% in 2011. While still accounting for a modest global share, Vietnam posted the highest growth rate in semiconductor exports between 2011 and 2021, at 37.6% CAGR.  

In 2023, semiconductor device exports hit US$7.53 billion in value, with over half of that total going to the U.S., followed by China and Canada. However, testing and packaging make up a small fraction of the semiconductor value chain, meaning Vietnam isn’t yet enjoying the true windfall of this industry.  

For example, 80% of capex from chip companies goes toward wafer manufacturing, a process dominated by TSMC and Samsung, with a handful of other companies – none Vietnamese – taking up the rest of the global chip fabrication share.   

Semiconductor fabrication plants – called ‘fabs’ – are wildly expensive, with the most advanced costing many billions of dollars. The price tag on TSMC’s under-construction fab in Arizona is currently US$40 billion

Given those prohibitive costs, Vietnam aims to expand testing and packaging investments, while eventually targeting the lucrative design stage – i.e., where Nvidia makes its money. 

To that end, the government aims to train 50,000 engineers for the semiconductor industry by 2030, including 15,000 chip design engineers and 35,000 engineers across manufacturing, packaging, testing, and other fields. 

This hugely ambitious goal would address one of the biggest challenges facing the country’s chip industry: human resources. 

“A highly skilled workforce is the backbone of any successful semiconductor industry,” a representative from FPT Group said. “Despite having a young and talented IT talent pool, the shortage of high-skilled semiconductor personnel has always been a primary challenge for Vietnam.” 

FPT Group, meanwhile, hopes to be a domestic leader in this effort. With support from the government, FPT is focusing on talent development by investing in education and training programs that equip individuals with the necessary skills. In September 2023, FPT University partnered with FPT Semiconductor to set up a Department of Semiconductor and Microelectronics, aiming to develop a high-quality workforce and conduct research on microelectronics and semiconductors. 

FPT Group, and Vietnam more broadly, have their work cut out for them amid intense regional competition.  

Nvidia, Microsoft, and Google have each announced multi-billion dollar AI- and chip-related investments in Indonesia and Malaysia over the last year, while Vietnam hasn’t secured anything that large. 

Advanced economies like the U.S., which dominates the design market, are also trying to get a bigger share of the semiconductor pie, most notably through the 2022 CHIPS and Science Act that subsidizes chip fabrication.  

Amid that competition, the Ministry of Planning and Investment is drafting a decree for the to-be-launched Investment Support Fund, offering aid of up to 30% of the research and development (R&D) costs that businesses incur to attract more high-tech FDI. This will also include incentives related to corporate income tax, import-export tax, and land lease fees.  

While this initiative may take time to come online, Vietnam does have strengths, including a strong STEM-focused education system and lower labor costs. 

FPT, for their part, envisions a bright future: “We believe that Vietnamese engineers will be able to join the design process of modern semiconductor circuits, master packaging and testing technology, and work in semiconductor factories, thus gradually grasping technology in the production stage.  

We hope that as Vietnam continues to grow as a global hub for semiconductor talent, we will also see increased investment from global semiconductor corporations, leading to the expansion of facilities and further development of the supply chain.” 

FPT Semiconductor, which focuses on power management chip design, is a domestic pioneer in semiconductor design for commercial purposes. They are currently fulfilling orders for 70 million chips from Japan, South Korea, and Taiwan for medical equipment and microelectronics applications. 

Writing credit Michael Tatarski 

Join us for a Webinar hosted by Dynam Capital, the fund manager for VietNam Holding Limited (LSE: VNH) at 10 AM UK time, Thursday 8 August 2024, as we discuss the growing potential for Vietnam to participate in the global IT and semiconductor supply chain with FPT Corporation (HOSE: FPT) our largest portfolio holding.  

FPT is the most valuable technology brand in Vietnam. The company has transformed itself from an IT services company to an end-to-end digital transformation service provider and operates from 290 offices and branches across 29 countries and continues to expand its overseas presence.  

Register to watch the Webinar 

FTSE 100 within touching distance of all-time high as HSBC and miners lead the charge higher

The FTSE 100 surged higher on Wednesday as heavyweight HSBC and mining gave investors something to shout about. HSBC earnings significantly beat expectations, and miners jumped on the tailcoats of a commodities rally.

Today’s rally takes the FTSE 100 within touching distance of the all-time record high of 8,445 set in May this year.

While US technology shares have been under the spotlight after a rip-roaring rally left the sector with frothy valuations, the FTSE 100’s more defensive sectors have quietly held their own, giving cyclical mining and banking sectors the opportunity to rocket higher on Wednesday and take London’s leading index 8% higher year-to-date.

“Commodities came to the rescue, driving strong gains for the FTSE 100 and helping the UK stock market to buck the sell-off that gripped Wall Street yesterday,” said Russ Mould, investment director at AJ Bell.

“A 1.2% gain from the FTSE 100 was driven by Shell, BP and Glencore following a bounce in the oil price. Brent Crude jumped 2% to $79.61 per barrel, rebounding after declining for five days straight. 

“The index was also propelled by a positive reaction to HSBC’s latest share buyback news and a bounce-back from Diageo after yesterday’s troublesome financial results.”

HSBC added the most points to the FTSE 100’s gain on Wednesday after a massive profit and bumper share buyback beat fired-up investor demand for the global bank.

“HSBC delivers a massive profit beat as Noel Quinn says goodbye. The beat was split evenly across strength in underlying profitability and lower impairments. Borrowers are clinging on, even improving in some places, despite interest rates that many haven’t had to handle for quite some year, or ever in the case of younger borrowers. The outlook on loan losses is decent too, with management signalling the worst of the Chinese commercial real estate drama now in the rear-view mirror” said Matt Britzman, senior equity analyst at Hargreaves Lansdown.

“A greater focus on Wealth Management is bearing fruit and should allow HSBC to take advantage of the burgeoning middle class in regions like China. There’s also the added bonus of diversification away from interest rates, a key strategic priority over the past few years. With rate cuts expected around the globe, these actions should give Georges Elhedery a strong foundation to work from when he steps up to the CEO seat in September.”

GSK

Long a disappointing investment for shareholders, GSK has shown signs of life in recent quarters. A 13% increase in underlying revenue in Q2 and increased guidance threatened to signal momentum for the pharmaceutical giant on Wednesday. However, investors were unimpressed with the better-than-expected results, and GSK shares were down 2% at the time of writing.

Taylor Wimpey

Taylor Wimpey was also among the better performers on Wednesday after revenue and completions fell less than expected in the first half of the year.

“Despite interest and mortgage rates remaining high, Taylor Wimpey’s had a solid first half. Operating profit landed 12% ahead of market forecasts, although this figure benefitted from increased land sales versus the prior year,” expalined Aarin Chiekrie, equity analyst, Hargreaves Lansdown

“The net private sales rate moved slightly higher too, indicating a small improvement in consumer confidence and their ability to commit to big purchases. 4,728 new homes were completed in the period, with the full-year total now expected to come in at the top end of the group’s prior 9,500-10,000 range. That’s given management the confidence to issue full-year operating profit guidance, which is now expected to be in line with current market expectations of around £416mn, or only a decline of around 10% year-over-year.”

Taylor Wimpey shares were 1.2% higher at the time of writing.

Greatland Gold – Determined To Get Total Control Of Havieron Gold-Copper Project By Buying Out Newmont 

In this morning’s June Quarter Update from Greatland Gold (LON:GGP) the group is determined to get total control of its Havieron gold-copper project. 

The £377m-capitalised Greatland is a mining development and exploration company focused primarily on precious and base metals, its flagship asset is the world-class Havieron gold-copper project in the Paterson Province of Western Australia. 

It was discovered by Greatland and is presently under development in joint venture with world gold major, Newmont Corporation which has stated that it considered its 70% interest in Havieron and ownership of the nearby Telfer gold-copper mine as non-core assets which it intends to divest.   

Under the Havieron joint venture agreement, Greatland holds a right of last refusal in respect of a sale by Newmont of its joint venture interest in Havieron to a third party.   

Greatland continues to consider itself strongly positioned should there be an opportunity to consolidate ownership of Havieron on accretive terms for Greatland’s shareholders. 

The Telfer Gold Mine 

Havieron is located some 45km east of Newcrest’s existing Telfer gold mine.  

The box cut and decline to the Havieron orebody commenced in February 2021.  

By the end of June the total development had exceeded 3,060m including over 2,110m of advance in the main access decline.   

Subject to a positive feasibility study and Decision to Mine, Havieron is intended to leverage the existing Telfer infrastructure and processing plant.   

Importantly, the group has stated that access to Telfer would de-risk the development and would reduce capital expenditure. 

Managing Director Shaun Day stated that: 

“At Havieron, good progress was made in the quarter with the EPA’s formal decision to assess the environmental approval application.   

In respect of Newmont’s announced intention to dispose of its interest in Havieron and nearby Telfer mine, we continue to consider ourselves strongly positioned for any potential opportunity to consolidate ownership of Havieron on accretive terms for our existing shareholders. 

Excellent progress is being made across Greatland’s exploration portfolio, and we are pleased to share a detailed review and look-ahead for our high priority exploration projects in this release.   

FY25 promises to be a busy year for our exploration team and we look forward to providing updates on our activities.” 

Looking For Early News Of ‘First Ore’ 

The group has a proven track record of discovery and exploration success and is pursuing the next generation of tier-one mineral deposits by applying advanced exploration techniques in under-explored regions.  

Greatland has a number of exploration projects across Western Australia and in parallel to the development of Havieron is focused on becoming a multi-commodity miner of significant scale. 

The group’s shares, which were up to 11.25p in late November last year, are currently trading at around 7.30p and look capable of advancing in price, especially if we soon get any news of ‘first ore’ from the decline development. 

Genedrive achieves major milestone with NICE final guidance

The UK’s National Institute for Health and Care Excellence (NICE) has issued final guidance recommending the use of Genedrive’s CYP2C19 genotyping to guide clopidogrel treatment in patients who have suffered an Ischaemic Stroke (IS) or Transient Ischaemic Attack (TIA). NICE specifically recommends the Genedrive® CYP2C19-ID test as the preferred point-of-care testing solution.

Genedrive plc’s CYP2C19-ID test, which uses a non-invasive cheek swab, quickly identifies six genetic variants of the CYP2C19 gene. This information helps clinicians optimize treatment plans for stroke patients.

The NICE committee’s decision was based on a systematic review of clinical and economic impacts. They concluded that CYP2C19 genetic testing is both beneficial for patients with certain genetic variants and cost-effective compared to not testing.

With this recommendation and existing UKCA certification, Genedrive plc is now poised to commercialise its product in the UK and select Middle Eastern countries.

“We are delighted with this final guidance from NICE recommending implementation of CYP2C19 genotype-guided use of Clopidogrel in IS and TIA patients in the NHS to reduce risk of recurrent strokes, and recommendation of our CYP2C19 ID-kit as the point-of-care interventional platform of choice,” said James Cheek, CEO of genedrive plc.

“This represents a key milestone in our commercialisation plans for the product, and further solidifies our business strategy of leading provision of cost-effective solutions for pharmacogenetics in time critical emergency healthcare situations. We are proud to be at the forefront of the emergence of near-patient genetic testing in emergency healthcare to facilitate optimal personalised therapeutic choices and ultimately improve patient outcomes.”

Taylor Wimpey completions fall as headwinds persist

Taylor Wimpey has reported a decrease in completions and revenue for the first half of 2024, reflecting ongoing challenges in the housing market.

The impact of higher interest rates is all too evident in Taylor Wimpey’s numbers as falling sales continued in the first half of 2024.

In the first half of 2024, Taylor Wimpey’s group completions, including joint ventures, fell to 4,728 homes from 5,120 in the same period last year. This decline in completions contributed to a decrease in group operating profit, which fell to £182.3 million from £235.6 million in H1 2023.

The company noted £18.6 million of profit generated from land sales, compared to just £2.7 million in the previous year.

Despite significant headwinds, Taylor Wimpey reported a slight improvement in its net private sales rate, which increased to 0.75 in H1 2024 from 0.71 in H1 2023. It may be too early to call the data green shoots but it will be of some solace for investors.

Looking ahead, Taylor Wimpey remains cautiously optimistic. The company expects full-year UK completions, excluding joint ventures, to be towards the upper end of its previous guidance range of 9,500 to 10,000 homes. This positive outlook is supported by a robust order book, which stood at £2,102 million as of July 28, 2024, representing 7,667 homes.

“Looking to the second half, our performance to date means we now expect to deliver 2024 full year UK completions towards the upper end of our previous guidance range of 9,500 to 10,000 and Group operating profit in line with current market expectations,” said Jennie Daly, Chief Executive.

The company is focusing on building its order book to optimize value and position itself for growth from 2025, assuming supportive market conditions. Taylor Wimpey reports excellent visibility for 2025 completions, owning and controlling all necessary land, with most having detailed planning permission.

In the medium term, Taylor Wimpey is actively preparing for potential planning changes and developing high-quality planning applications. The company has approximately 30,000 applications in the planning process and additional applications ready if proposed changes to green belt regulations come into effect.

Despite the current challenges, Taylor Wimpey remains committed to shareholder returns announcing a 2024 interim dividend of 4.80 pence per share, slightly up from 4.79 pence per share in H1 2023, which will be paid in November.

Tekcapital portfolio company MicroSalt secures major Canadian supermarket placement

MicroSalt has secured a significant distribution agreement with Loblaws, one of Canada’s largest and most established supermarket chains.

Loblaws, a Canadian retail giant, operates an extensive network of over 2,400 stores across the country. This partnership provides MicroSalt with an opportunity to reach another vast customer base, adding to its growing number of global distribution channels.

For context, Loblaws food retail segment, which covers the supermarket business, reported revenues of over CAD$9.4bn (£5.2bn) in their most recent quarterly earnings.

Today’s agreement includes placing 2oz and 6oz MicroSalt saltshakers in Loblaws stores. The products are expected to hit shelves in September/October 2024.

This distribution deal with such a prominent retailer represents another major milestone for MicroSalt after listing in London earlier this year with potential exposure to millions of Canadian consumers.

In addition, to support and further expand its sales within the Canadian market, MicroSalt has also partnered with LeBeau Excel, a leading food broker specialising in the natural and organic industry.

“We are extremely excited about the placement of MicroSalt® shakers in Loblaws,” said Rick Guiney, CEO of MicroSalt.

“Loblaws is one of the largest supermarket chains in Canada and a prominent fixture in the Canadian food landscape. United Natural Foods will be the distribution partner to support the Loblaws placement. Additionally, we are enthusiastic to partner with LeBeau Excel to expand our business, across all customer channels in Canada.”

Tekcapital holds a 77% stake in Microsalt worth around £30m as of yesterday’s close.

Microsoft shares tank in after-hours trade despite beating headline earnings estimates

Microsoft share sank in the US after-market following the release of quarterly earnings that beat analyst consensus estimates but didn’t wow increasingly sceptical Wall Street traders.

Microsoft headline earnings came in better than expected, with revenue and EPS beating estimates. However, expectations were high going into the results, and shares fell in the after-market as investors reacted to disappointing cloud revenue that narrowly missed estimates. 

“For the quarter, Microsoft reported earnings per share of $2.95 on revenue of $64.7 billion,” said Amish Patel, Head of Equity Research at Charles Stanley.

“Wall Street was anticipating EPS of $2.94 on revenue of $64.5 billion, according to data compiled by Bloomberg. Microsoft reported EPS of $2.69 and revenue of $56.2 billion during the same period last year.

“Microsoft’s overall Cloud revenue came in at $36.8 billion, in line with expectations of $36.8 billion, but the company’s Intelligent Cloud revenue, which includes its Azure services, fell short, coming in at $28.5 billion versus expectations of $28.7 billion.”

Patel continued to explain that the market was focusing on the cloud business as an indicator of growth in Microsoft’s AI business and suggested patience is required for this area of the business to flourish. However, patience is in short supply after sharp declines in tech share of late.

“Shares are trading 6% lower as investors were hoping for an acceleration in cloud growth driven by AI investments. Ultimately, the payoff from AI investments will take time and we continue to believe Microsoft remains well placed to benefit from AI adoption,” Patel said.

The drop in shares represents elevated expectations for tech companies, signalling an earnings beat is not enough to satisfy investors who seemingly want to see tech smash earnings estimates.